Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis

The investigator will enroll subjects according to Inclusion/Exclusion criteria after obtaining Informed Consent Form from each subject. Enrolled subjects will administer Zoledronic Acid 5mg/100mL once on baseline (Visit 1). The demographic data, prescription data, and medical history, etc will be collected based on the approved protocol. Additionally using application, subject's self-awareness symptoms and subject's questionnaire for medical outcome short form health survey (SF-36) every day from the baseline for 4 days will be collected.

Investigator will also collect any occurrence of fracture through electronic medical record until 48 weeks (Visit 2) from baseline visit.

Inclusion criteria

• Male and female adults 19 years of age or older at the time of screening visit
• A person who is scheduled to administer the research drug according to the medical judgment of the researcher based on the permission
• A person who can understand the information provided to the person and can voluntarily sign a written consent form

Exclusion criteria

• Those subject to contraindications to administration according to the drug approval requirements for research

• Patients with hypersensitivity to the components of this drug or other bisphosphonate drugs Hypocalcemia
• Patients with severe renal impairment whose creatinine clearance rate is less than 35 mL/min (patients must measure serum creatinine and creatinine clearance before receiving the study drug).
• Patients receiving Zometa for cancer as an indication
• Pregnant women, women who may be pregnant, and lactating women
• Patients participating in other clinical trials (However, registration is possible if you have not received investigational drugs or are participating in other non-interventional observational studies.)
• In addition to the above, patients whom the researcher (physician in charge) determines are not suitable as subjects of this observational study.